FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of $0.44, $0.13 better than the analyst estimate of $0.31. Revenue for the quarter came in at $217.8 million versus the consensus estimate of $192.29 million.
"Maravai had an incredibly strong first half of 2021, and we feel very good about... More

